References
- Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8–19
- Davidson JRT, Meltzer-Brody SE. The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? J Clin Psychiatry 1999;60(Suppl):4–9
- Hirschfeld R, Keller M, Panico S, et al. The national depressive and manic-depressive association consensus statement on the undertreatment of depression. JAMA 1997;227:333–40
- Saklad SR. Pharmacoeconomic issues in the treatment of depression. Pharmacotherapy 1995;15:76–83
- Panzarino PJ Jr, Nash DB. Cost-effective treatment of depression with selective serotonin reuptake inhibitors. Am J Manag Care 2001;7:173–84
- Leon AC, Solomon DA, Mueller TI, et al. A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness. Am J Psychiatry 2003;160:727–33
- Meyers BS, Sirey JA, Bruce M, et al. Predictors of early recovery from major depression among persons admitted to community based clinics: an observational study. Arch Gen Psychiatry 2002;59:729–35
- Cohen LJ. Pharmacoeconomic issues in the treatment of depression. Formulary 1995;30 (Suppl):20–5
- Fabre LF, Abuzzahab FS, Amin M, et al. Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol Psychiatry 1995;38:592–602
- Lexapro® prescribing information. Forest Pharmaceuticals, Inc. Revised February 2005
- Zoloft® prescribing information. Pfizer, Inc. Revised February 2005
- Dunner DL, Dunbar GC. Optimal dose regimen for paroxetine. J Clin Psychiatry 1992;53(Suppl):21–6
- Owens MJ, Knight DL, Nemeroff CB. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 2001;50:345–50
- Sanchez C, Bergqvist PB, Brennum LT, et al. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology (Berl) 2003;67:353–62
- Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003;64:1465–75
- Croghan TW. The controversy of increased spending for antidepressants. Health Affairs 2001;20:129–35
- Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–9
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62
- Guy W. ECDEU Assessment Manual for Psychopharmacology. Washington, DC: Superintendent of Documents, US Government Printing Office, US Department of Health, Education, and Welfare Publication No. 76–338; 1976
- Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50–5
- Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385–401
- Endicott J, Nee J, Harrison W, Blumenthal R. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 1993;29:321–6
- National Committee for Quality Assurance Programs: The health plan employer data and information set (HEDIS®). Internet: www.ncqa.org/Programs/HEDIS/ accessed July 29, 2005
- Ventura D, Armstrong EP, Skrepnek GH, et al. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. Curr Med Res Opinion 2007; 23:245–50
- Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 2002;63:331–6
- Sullivan PW, Valuck R, Saseen J, et al. A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions. CNS Drugs 2004;18:911–32
- McLaughlin TP, Eaddy MT, Grudzinski AN. A claims analysis comparing citalopram with sertraline as initial pharmacotherapy for a new episode of depression: impact on depression-related treatment charges. Clin Ther 2004;26:115–24
- Physician fee schedule, Center for Medicare & Medicaid Services. Internet: www.cms.hhs.gov/physicians/pfs/default.asp accessed: January 3, 2005
- drugstore.com Online Pharmacy. Internet: www.drugstore.com accessed January 3, 2005